Patricia Kropf - Concepedia

Author

Patricia Kropf

Also Known As

Kropf, Patricia, P L Kropf, P. Kropf, P.L. Kropf, Patricia Kropf, Patricia L Kropf, Patricia L. Kropf, Patricia Lamont Kropf

113

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center The University of Texas MD Anderson Cancer Center Roswell Park Comprehensive Cancer Center Temple University Cornell University

About

Patricia Kropf is an author at Fox Chase Cancer Center specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	2.6K
2	Health Sciences	6	6	936
3	Classical Hematology	2	2	153
4	Public Health	1	1	85
5	Cellular Therapies	1	1	21

Patricia Kropf

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Functional genomic landscape of acute myeloid leukaemia Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly, Nature Hematological MalignancyChromatinFunctional GenomicsMixed-phenotype Acute LeukemiaGenetics	2018	1.4K
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, Journal of the National Comprehensive Cancer Network Hematological MalignancyVersion 3.2017OncologyHealth SciencesMixed-phenotype Acute Leukemia	2017	651
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial Hagop M. Kantarjian, Gail J. Roboz, Patricia Kropf, The Lancet Oncology Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyClinical Trials	2017	152
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial Guillermo Garcia‐Manero, Gail J. Roboz, Katherine Walsh, The Lancet Haematology Hematological MalignancyMedicineHematologyClinical TrialsPathology	2019	91
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017 Arnel Pallera, Jessica K. Altman, Ellin Berman, Journal of the National Comprehensive Cancer Network FertilityMixed-phenotype Acute LeukemiaReproductive HealthNccn Guidelines InsightsGynecology	2016	85
Chronic Myelogenous Leukemia, Version 1.2014 Susan O’Brien, Jerald P. Radich, Camille N. Abboud, Journal of the National Comprehensive Cancer Network Hematological MalignancyTranslational MedicineMedicineMixed-phenotype Acute LeukemiaMetronomic Therapy	2013	82
Chronic Myelogenous Leukemia, Version 1.2015 Susan O’Brien, Jerald P. Radich, Camille N. Abboud, Journal of the National Comprehensive Cancer Network Mixed-phenotype Acute LeukemiaImmunologyPathologyChronic Myelogenous LeukemiaImmunotherapy	2014	71
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology Ruben A. Mesa, Catriona Jamieson, Ravi Bhatia, Journal of the National Comprehensive Cancer Network	2016	71
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia Gail J. Roboz, Hagop M. Kantarjian, Karen Yee, Cancer	2017	64
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch, Blood	2012	51

Page 1